pancan.ai/Ask
what is known about trial:nct:NCT06202066
Understood asRecord NCT06202066View getStudy → table
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas NCT06202066↗ Outcome: Ongoing
Computed from the knowledge API (getStudy); every record links to its source.